Article info
PDFTherapeutics
Systematic review
Tricyclic antidepressants reduce frequency of tension-type and migraine headaches compared with placebo, and intensity of headaches compared with SSRIs, but cause greater adverse effects
- Correspondence to Paul D Molyneux
West Suffolk Hospital NHS Trust, Hardwick Lane, Bury St Edmunds, Suffolk IP29 4HP, UK; paul.molyneux{at}wsh.nhs.uk
Citation
Tricyclic antidepressants reduce frequency of tension-type and migraine headaches compared with placebo, and intensity of headaches compared with SSRIs, but cause greater adverse effects
Publication history
- First published January 19, 2011.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions